[1] |
Prost⁃Squarcioni C, Caux F, Schmidt E, et al. International Bullous Diseases Group: consensus on diagnostic criteria for epidermolysis bullosa acquisita[J]. Br J Dermatol, 2018,179(1):30⁃41. doi: 10.1111/bjd.16138.
|
[2] |
Holtsche MM, van Beek N, Hashimoto T, et al. Diagnosis of epidermolysis bullosa acquisita: multicentre comparison of different assays for serum anti⁃type Ⅶ collagen reactivity[J]. Acta Derm Venereol, 2021,101(3):adv00420. doi: 10.2340/00015555⁃3774.
|
[3] |
王媛, 余美文, 向睿宇, 等. 盐裂皮肤-间接免疫荧光方法优化及在大疱性类天疱疮抗体检测中的应用[J]. 中华皮肤科杂志, 2022,55(1):12⁃15. doi: 10.35541/cjd.20201126.
|
[4] |
Iranzo P, Herrero⁃González JE, Mascaró⁃Galy JM, et al. Epidermolysis bullosa acquisita: a retrospective analysis of 12 patients evaluated in four tertiary hospitals in Spain[J]. Br J Dermatol, 2014,171(5):1022⁃1030. doi: 10.1111/bjd.13144.
|
[5] |
Vorobyev A, Ludwig RJ, Schmidt E. Clinical features and diagnosis of epidermolysis bullosa acquisita[J]. Expert Rev Clin Immunol, 2017,13(2):157⁃169. doi: 10.1080/1744666X.2016.1221343.
|
[6] |
Hashimoto T, Jin Z, Ishii N. Clinical and immunological studies for 105 Japanese seropositive patients of epidermolysis bullosa acquisita examined at Kurume University[J]. Expert Rev Clin Immunol, 2016,12(8):895⁃902. doi: 10.1080/1744666X.2016.1196136.
|
[7] |
Reddy H, Shipman AR, Wojnarowska F. Epidermolysis bullosa acquisita and inflammatory bowel disease: a review of the literature[J]. Clin Exp Dermatol, 2013,38(3):225⁃229; quiz 229⁃230. doi: 10.1111/ced.12114.
|
[8] |
Kridin K, Kneiber D, Kowalski EH, et al. Epidermolysis bullosa acquisita: a comprehensive review[J]. Autoimmun Rev, 2019,18(8):786⁃795. doi: 10.1016/j.autrev.2019.06.007.
|
[9] |
Kridin K, Vorobyev A, Papara C, et al. Risk factors and sequelae of epidermolysis bullosa acquisita: a propensity⁃matched global study in 1,344 patients[J]. Front Immunol, 2022,13:1103533. doi: 10.3389/fimmu.2022.1103533.
|
[10] |
Schmidt E, Zillikens D. Pemphigoid diseases[J]. Lancet, 2013,381(9863):320⁃332. doi: 10.1016/S0140⁃6736(12)61140⁃4.
|
[11] |
Seta V, Aucouturier F, Bonnefoy J, et al. Comparison of 3 type Ⅶ collagen (C7) assays for serologic diagnosis of epidermolysis bullosa acquisita (EBA)[J]. J Am Acad Dermatol, 2016,74(6):1166⁃1172. doi: 10.1016/j.jaad.2016.01.005.
|
[12] |
Terra JB, Jonkman MF, Diercks GF, et al. Low sensitivity of type Ⅶcollagen enzyme⁃linked immunosorbent assay in epidermolysis bullosa acquisita: serration pattern analysis on skin biopsy is required for diagnosis[J]. Br J Dermatol, 2013,169(1):164⁃167. doi: 10.1111/bjd.12300.
|
[13] |
Kim JH, Kim YH, Kim SC. Epidermolysis bullosa acquisita: a retrospective clinical analysis of 30 cases[J]. Acta Derm Venereol, 2011,91(3):307⁃312. doi: 10.2340/00015555⁃1065.
|
[14] |
Koga H, Prost⁃Squarcioni C, Iwata H, et al. Epidermolysis bullosa acquisita: the 2019 update[J]. Front Med (Lausanne), 2018,5:362. doi: 10.3389/fmed.2018.00362.
|
[15] |
Ahmed AR, Gürcan HM. Treatment of epidermolysis bullosa acquisita with intravenous immunoglobulin in patients non⁃responsive to conventional therapy: clinical outcome and post⁃treatment long⁃term follow⁃up[J]. J Eur Acad Dermatol Venereol, 2012,26(9):1074⁃1083. doi: 10.1111/j.1468⁃3083. 2011.04205.x.
|
[16] |
Gordilho JO, Miyamoto D, Maruta CW, et al. Persistence of IgG4 as a potential serological marker of disease activity in patients with epidermolysis bullosa acquisita treated with rituximab[J]. J Eur Acad Dermatol Venereol, 2024,38(1):e45⁃e47. doi: 10. 1111/jdv.19413.
|